FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40537811000001105: Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2221481000001114 Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2221491000001111 Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Is a Ondansetron 4mg orodispersible tablets 10 tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has AMP Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Aristo Pharma Ltd) 10 tablet 2 x 5 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start